logo
Search
  • POA Pharma Scandinavia AB signs distribution agreement with FederalMed, Buenos Aires, Argentina

    POA Pharma Scandinavia AB signs distribution agreement with FederalMed, Buenos Aires, Argentina for marketing and sale of POA Pharma´s products within the competence area, Inborn Error of Metabolism in Argentina.

     

    Federal Med is a leading regional pharmaceutical firm, with offices in Argentina, Brazil, Chile, Uruguay & Paraguay.

    Our interdisciplinary team, with over 30 years of experience in the pharmaceutical industry, is made up of seasoned professionals that held managerial positions in several  Multinational Pharmaceuticals in Argentina and abroad; lead Bio-Tech projects and served as specialists in foreign trade and Regulatory Affairs.

    Our mission is to facilitate access to regional patients suffering from rare diseases, to the same life preserving therapeutic treatments available in the more developed regions of the world.

    Our extensive background in the pharma industry, allow us to identify unmet needs for patients and health care providers in the following areas:

    -Orphan Drugs

    -Metabolic Diseases

    -Rare Diseases

    -Medical Foods, &

    -Medical Devices

     

    FederalMed is very glad and proud to announce, it has come to an agreement with POA Pharma, for the distribution of POAs range of unique metabolic diseases product offering.

    The addition of POAs inborn errors of metabolism, portfolio, is a step forward for the quality of life of patients suffering from PKU in Argentina. This agreement comes in hand with federalMed mission of providing better therapeutic outcomes to the populations suffering from these very specific diseases. We would like to thank POAs management for their support throughout this process and their confidence deposited in our capabilities.

     (http://www.orpharma.com).

    POA Pharma – The Boutique Healthcare Company

     

    Brief History

    POA Pharma was on the market March 2011. Today the company have offices in four Nordic countries and in US. POA Pharma works within nine different competence areas having export agreements with 30 countries and agreements with pharmaceutical producers in 11 countries.

     

    An Export Company.

    Since 2013, POA Pharma have signed distribution agreements for it´s metabolic assortment in 27 countries; Australia, Argentina, Bolivia, Botswana, Brazil, Canada, Chile, Colombia, Czech Republic, Holland, Honduras,
    Ireland, Island, Italy, Malaysia, Mexico
    , Mozambique, Namibia, New Zeeland, Singapore, Slovakia,
     South Africa, Turkey
    , UK, USA,
     Uruguay, Zimbabwe,

     

    A Boutique Company

    POA Pharma is a market oriented Boutique Healthcare Company, working in close contact with healthcare organizations, professionals and pharmacies in the 26 million population Nordic countries.  

    Boutique is French for “shop”, via Latin from Greek apothēkē, “sto, rehouse”. In contemporary business language boutique is a specialized firm with a unique concept.

     “ A Boutique is where you expect to be positive surprised when finding what the average shop cannot offer. “

     

    For more information please contact:

    POA Pharmna at or

    FederalMed
    E-mail:

     

    Leave a reply →